Product information
Product Overview
BPC-157 + TB-500 Blend combines two complementary research peptides in a single 20mg formulation for laboratory research. BPC-157 (pentadecapeptide, 10mg) focuses on angiogenesis and growth factor signalling, while TB-500 (Thymosin Beta-4 analogue, 10mg) targets actin-binding and cellular motility. Products selected for website presentation meet Solatide Biosciences' ≥99% purity standard based on available third-party documentation. This combination enables investigation of synergistic angiogenesis mechanisms and multi-pathway cellular migration in laboratory models.
Related: Research Peptides | Compare BPC-157 vs TB-500 | Research Peptides Guide
Technical Specifications
Batch-specific third-party documentation available. Reports may include testing from independent laboratories such as Janoshik, Chromate, and Freedom Diagnostics, depending on the batch. View our COA & Lab Testing page for details.
Research Applications
- Synergistic Pathway Studies: Investigate combined angiogenesis and cellular migration mechanisms in experimental models.
- Comparative Peptide Research: Compare combination effects versus individual BPC-157 or TB-500 in multi-pathway investigation.
- Multi-Target Pathway Investigation: Study interactions between growth factor signalling and cytoskeletal regulation systems.
- Analytical Concentration: In-vitro assays typically utilise a range of 1 nM to 10 μM to establish combined pathway metrics.
This analytical standard is strictly for in-vitro laboratory research use only.